Variant report
Variant | nsv522251 |
---|---|
Chromosome Location | chr17:50530328-50538567 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10515013 | chr17:50530328-50530329 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs77860235 | chr17:50530349-50530350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs145993601 | chr17:50530377-50530378 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs967316 | chr17:50530391-50530392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs373808564 | chr17:50530411-50530412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs566485957 | chr17:50530418-50530419 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs574694484 | chr17:50530438-50530439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs543204537 | chr17:50530452-50530453 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs12325953 | chr17:50530558-50530559 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs138883171 | chr17:50530603-50530604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs545946321 | chr17:50530609-50530610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs559369182 | chr17:50530662-50530663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs528047345 | chr17:50530663-50530664 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs1424319 | chr17:50530720-50530721 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs561380664 | chr17:50530741-50530742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs530426216 | chr17:50530747-50530748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs10515014 | chr17:50530748-50530749 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs371598207 | chr17:50530750-50530751 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs35041771 | chr17:50530757-50530758 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs548338419 | chr17:50530775-50530776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs150297665 | chr17:50530787-50530788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs538731607 | chr17:50530815-50530816 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs552284077 | chr17:50530816-50530817 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs566189131 | chr17:50530857-50530858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs115794559 | chr17:50530901-50530902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs116247348 | chr17:50530933-50530934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs189350395 | chr17:50530935-50530936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs374040825 | chr17:50530998-50530999 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs537381506 | chr17:50531000-50531001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs557175235 | chr17:50531019-50531020 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs577136547 | chr17:50531078-50531079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs75559260 | chr17:50531113-50531114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs552758041 | chr17:50531158-50531159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs78793195 | chr17:50531173-50531174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs541415588 | chr17:50531209-50531210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs549857820 | chr17:50531252-50531253 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs577575425 | chr17:50531323-50531324 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs530318984 | chr17:50531324-50531325 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs370742049 | chr17:50531373-50531374 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs563521962 | chr17:50531408-50531409 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs180672913 | chr17:50531415-50531416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs552371818 | chr17:50531429-50531430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs148521009 | chr17:50531458-50531459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs954263 | chr17:50531506-50531507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs565075592 | chr17:50531509-50531510 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs954262 | chr17:50531517-50531518 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs202118644 | chr17:50531544-50531545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs371459327 | chr17:50531546-50531547 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Melanoma | 18172304 | CNVD |
Moyamoya disease | 22323933 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chordoma | 21602918 | CNVD |
Neurofibromatosis | 20686819 | CNVD |
Peripheral nerve sheath tumors | 20686819 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Breast cancer | 21264507 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Gastric cancer | 17167181 | CNVD |
Breast cancer | 19287154 | CNVD |
Leukemia | 20874852 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 20953835 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Bladder cancer | 21909424 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Breast cancer | 21509527 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Chordoma | 18071362 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Cancer | 16751803 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 21523713 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:50528400-50531600 | Enhancers | Cortex derived primary cultured neurospheres | brain |